REG - Capital Group Co. Sanofi SA Amgen Inc. - Form 8.3 - Horizon Therapeutics PLC

AmgenAnnouncement

06/12/2022 13:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221206:nRSF7919Ia&default-theme=true

RNS Number : 7919I  Capital Group Companies Inc  06 December 2022

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

 1.                                 KEY INFORMATION

 Name of person dealing                                                   The Capital Group Companies, Inc.
 Company dealt in                                                         Horizon Therapeutics PLC
 Class of relevant security to which the                                  US$0.0001 ordinary shares (IE00BQPVQZ61)

 dealings being disclosed relate
 Date of dealing                                                          05 December 2022

 2.                                 INTERESTS AND SHORT POSITIONS

 (a)                                Interests and short positions (following dealing) in the class of relevant
                                    security

                                    dealt in

                                                           Long                                         Short
                                                           Number                        (%)            Number         (%)
 (1)         Relevant securities                           10,076,263 shares             4.45 %
 (2)         Derivatives (other than options):
 (3)         Options and agreements to purchase/sell:
             Total                                         10,076,263 shares             4.45 %

 (b)                                Interests and short positions in relevant securities of the company, other
                                    than the

                                    class dealt in

 Class of relevant security:                               Long                                         Short
                                                           Number                        (%)            Number         (%)
 (1)         Relevant securities
 (2)         Derivatives (other than options):
 (3)         Options and agreements to purchase/sell:
             Total

 3.               DEALINGS

 (a)              Purchases and sales

 Purchase/sale                                                                                            Number of relevant securities                                                          Price per unit
 Purchase                                                                                                 448 shares                                                                             98.4800 - USD
 Purchase                                                                                                 118 shares                                                                             104.8500 - USD
 Purchase                                                                                                 76 shares                                                                              98.8150 - USD
 Purchase                                                                                                 47 shares                                                                              99.0151 - USD
 Purchase                                                                                                 23 shares                                                                              99.0347 - USD
 Sale                                                                                                     9,999 shares                                                                           100.1861 - USD

 (b)              Derivatives transactions (other than options transactions)

 Product name                                                                  Nature of transaction                                           Number of relevant securities                               Price per unit

 e.g. CFD

 (c)              Options transactions in respect of existing relevant securities

 (i)              Writing, selling, purchasing or varying

 Product name e.g. call option     Writing, purchasing, selling, varying etc.  Number of securities to which the option relates      Exercise price      Type, e.g. American, European etc.      Expiry date         Option money paid/ received per unit

 (ii)             Exercising

 Product name                                                                  Number of securities                                                                          Exercise price per unit

 e.g. call option

 (d)              Other dealings (including subscribing for new securities)

 Nature of transaction                                                         Details                                                                                       Price per unit (if applicable)

 4.                                 OTHER INFORMATION

 Agreements, arrangements or understandings relating to options or derivatives

 Full details of any agreement, arrangement or understanding between the person
 disclosing and any other person relating to the voting rights of any relevant
 securities under any option referred to on this form or relating to the voting
 rights or future acquisition or disposal of any relevant securities to which
 any derivative referred to on this form is referenced. If none, this should be
 stated.
 None

 Is a Supplemental Form 8 attached?                                    NO

 Date of disclosure                                                    06 December 2022
 Contact name                                                          Art Romero
 Telephone number                                                      213 452 2709
 If a connected EFM, name of offeree/offeror with which connected
 If a connected EFM, state nature of connection

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEBKABQNBDDDBK